Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MNTA

Momenta Pharmaceuticals (MNTA) Stock Price, News & Analysis

Momenta Pharmaceuticals logo

About Momenta Pharmaceuticals Stock (NASDAQ:MNTA)

Advanced Chart

Key Stats

Today's Range
$52.48
$52.48
50-Day Range
$52.26
$52.49
52-Week Range
$12.21
$52.53
Volume
N/A
Average Volume
1.94 million shs
Market Capitalization
$6.25 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MNTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Momenta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MNTA Stock News Headlines

Johnson & Johnson Files for First FDA OK of Nipocalimab
Genoptix, Momenta Shares Headed for Gains
While Tariffs Crushed the Market, This Trading Strategy Stayed GREEN
On the day the S&P 500 soared 9.5% and the Nasdaq jumped 12%, most investors were caught off guard. But a small group of traders stayed calm—and profitable. They were using Professor Jeff Bierman’s Genesis Cog system, designed to spot “stock hijacks” driven by algorithms, not headlines.
Eastman Kodak, Rambus: After-Hours Trading
See More Headlines

MNTA Stock Analysis - Frequently Asked Questions

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) announced its quarterly earnings data on Monday, August, 10th. The biotechnology company reported ($0.48) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by $0.06. The biotechnology company earned $6.61 million during the quarter, compared to the consensus estimate of $5.84 million. Momenta Pharmaceuticals had a negative trailing twelve-month return on equity of 61.44% and a negative net margin of 757.61%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Momenta Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), Exelixis (EXEL), Gilead Sciences (GILD), Novavax (NVAX), Bristol Myers Squibb (BMY) and Shopify (SHOP).

Company Calendar

Last Earnings
8/10/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:MNTA
CIK
1235010
Fax
N/A
Employees
131
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$290.05 million
Net Margins
-757.61%
Pretax Margin
N/A
Return on Equity
-61.44%
Return on Assets
-45.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.38
Quick Ratio
6.38

Sales & Book Value

Annual Sales
$23.87 million
Price / Sales
261.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.59 per share
Price / Book
11.43

Miscellaneous

Outstanding Shares
119,029,000
Free Float
N/A
Market Cap
$6.25 billion
Optionable
Optionable
Beta
1.71
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MNTA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners